Does CLOPIDOGREL BISULFATE Cause Interstitial lung disease? 144 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 144 reports of Interstitial lung disease have been filed in association with CLOPIDOGREL BISULFATE (Clopidogrel). This represents 0.3% of all adverse event reports for CLOPIDOGREL BISULFATE.
144
Reports of Interstitial lung disease with CLOPIDOGREL BISULFATE
0.3%
of all CLOPIDOGREL BISULFATE reports
26
Deaths
105
Hospitalizations
How Dangerous Is Interstitial lung disease From CLOPIDOGREL BISULFATE?
Of the 144 reports, 26 (18.1%) resulted in death, 105 (72.9%) required hospitalization, and 13 (9.0%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLOPIDOGREL BISULFATE. However, 144 reports have been filed with the FAERS database.
What Other Side Effects Does CLOPIDOGREL BISULFATE Cause?
Gastrointestinal haemorrhage (5,513)
Anaemia (3,043)
Dyspnoea (1,963)
Drug interaction (1,846)
Haemorrhage (1,762)
Drug ineffective (1,644)
Cerebral haemorrhage (1,603)
Dizziness (1,586)
Epistaxis (1,560)
Melaena (1,547)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which CLOPIDOGREL BISULFATE Alternatives Have Lower Interstitial lung disease Risk?
CLOPIDOGREL BISULFATE vs CLORAZEPATE
CLOPIDOGREL BISULFATE vs CLOSTRIDIUM TETANI TOXOID ANTIGEN
CLOPIDOGREL BISULFATE vs CLOTHIAPINE
CLOPIDOGREL BISULFATE vs CLOTIAZEPAM
CLOPIDOGREL BISULFATE vs CLOTRIMAZOLE